Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Smith

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|August 8, 2023
Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate CancerSandra C Ordonez-Rubiano, Chad A Maschinot, Sijie Wang, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 15, 2024
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell typesRachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez, et al.
Molecular Pharmacology|January 5, 2024
Extrahelical Binding Site for a 1<i>H</i>-Imidazo[4,5-c]quinolin-4-amine A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7Courtney L Fisher, Matteo Pavan, Veronica Salmaso, et al.
Frontiers in Genetics|December 13, 2023
Deep computational phenotyping of genomic variants impacting the SET domain of KMT2C reveal molecular mechanisms for their dysfunctionSalomão Dória Jorge, Young-In Chi, Jose Lizarraga Mazaba, et al.
Journal of Medicinal Chemistry|March 20, 2020
Validation and Characterization of Five Distinct Novel Inhibitors of Human CytomegalovirusArun Kapoor, Ayan K Ghosh, Michael Forman, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
Computational and Structural Biotechnology Journal|May 26, 2022
Structural bioinformatics enhances the interpretation of somatic mutations in KDM6A found in human cancersYoung-In Chi, Timothy J Stodola, Thiago M De Assuncao, et al.
Blood Advances|September 18, 2020
Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemiaMoua Yang, Wei Li, Calvin Harberg, et al.
Journal of Thrombosis and Haemostasis : JTH|April 10, 2023
Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formationMoua Yang, Joyce Chiu, Christina Scartelli, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|August 8, 2023
Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate CancerSandra C Ordonez-Rubiano, Chad A Maschinot, Sijie Wang, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 15, 2024
Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell typesRachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez, et al.
Molecular Pharmacology|January 5, 2024
Extrahelical Binding Site for a 1<i>H</i>-Imidazo[4,5-c]quinolin-4-amine A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7Courtney L Fisher, Matteo Pavan, Veronica Salmaso, et al.
Frontiers in Genetics|December 13, 2023
Deep computational phenotyping of genomic variants impacting the SET domain of KMT2C reveal molecular mechanisms for their dysfunctionSalomão Dória Jorge, Young-In Chi, Jose Lizarraga Mazaba, et al.
Journal of Medicinal Chemistry|March 20, 2020
Validation and Characterization of Five Distinct Novel Inhibitors of Human CytomegalovirusArun Kapoor, Ayan K Ghosh, Michael Forman, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
Computational and Structural Biotechnology Journal|May 26, 2022
Structural bioinformatics enhances the interpretation of somatic mutations in KDM6A found in human cancersYoung-In Chi, Timothy J Stodola, Thiago M De Assuncao, et al.
Blood Advances|September 18, 2020
Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemiaMoua Yang, Wei Li, Calvin Harberg, et al.
Journal of Thrombosis and Haemostasis : JTH|April 10, 2023
Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formationMoua Yang, Joyce Chiu, Christina Scartelli, et al.
Pageof 9